Cancer Evolution Simulator
Predict tumor progression and treatment response
Patient Data Input
Drag & drop VCF/MAF files
Tumor Growth Simulation
3D tumor growth visualization will appear here
Recommended Treatments
Pembrolizumab + Chemotherapy
Predicted Response Rate: 78%
EGFR Inhibitor
Predicted Response Rate: 65%
PARP Inhibitor
Predicted Response Rate: 58%
Molecular Pathway Analysis
| Pathway | Alterations | Activity Level | Drug Targets |
|---|---|---|---|
| PI3K/AKT/mTOR | PIK3CA E542K, PTEN loss |
|
Everolimus, Alpelisib |
| MAPK/ERK | KRAS G12D |
|
Trametinib |
| DNA Repair | BRCA2 truncation |
|
Olaparib, Talazoparib |
Progression-Free Survival
Kaplan-Meier curve will appear here
Metastasis Risk by Organ
Organ risk heatmap will appear here